PRC2 functions in development and congenital disorders
Orla Deevy1, Adrian P Bracken2
1Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.
Abstract:
Polycomb repressive complex 2 (PRC2) is a conserved chromatin regulator that is responsible for the methylation of histone H3 lysine 27 (H3K27). PRC2 is essential for normal development and its loss of function thus results in a range of developmental phenotypes. Here, we review the latest advances in our understanding of mammalian PRC2 activity and present an updated summary of the phenotypes associated with its loss of function in mice. We then discuss recent studies that have highlighted regulatory interplay between the modifications laid down by PRC2 and other chromatin modifiers, including NSD1 and DNMT3A. Finally, we propose a model in which the dysregulation of these modifications at intergenic regions is a shared molecular feature of genetically distinct but highly phenotypically similar overgrowth syndromes in humans.
Insights
Polycomb repressive complex 2 (PRC2) regulates development by methylating histone H3 lysine 27. Its loss causes developmental issues, and dysregulation links to human overgrowth syndromes.
Area of Science:
- Epigenetics and Chromatin Biology
- Developmental Biology
- Genetics
Background:
- Polycomb repressive complex 2 (PRC2) is a key epigenetic regulator.
- PRC2 catalyzes histone H3 lysine 27 (H3K27) methylation, crucial for gene silencing.
- Loss of PRC2 function leads to developmental abnormalities.
Purpose of the Study:
- To review recent advances in mammalian PRC2 activity.
- To summarize phenotypes associated with PRC2 loss of function in mice.
- To explore regulatory interplay and propose a model for overgrowth syndromes.
Main Methods:
- Literature review of mammalian PRC2 function.
- Analysis of mouse models with PRC2 loss of function.
- Discussion of regulatory interactions with NSD1 and DNMT3A.
Main Results:
- PRC2 is essential for normal development, with loss causing diverse phenotypes.
- Interplay exists between PRC2-mediated modifications and other chromatin modifiers.
- Dysregulation of modifications at intergenic regions is implicated in overgrowth syndromes.
Conclusions:
- PRC2's role in development and disease is complex.
- Interactions with other epigenetic modifiers fine-tune chromatin states.
- A unified molecular model for phenotypically similar overgrowth syndromes is proposed.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Master Transcription Regulators


